Menu

Aprea Therapeutics, Inc. APRE

Full chart Compare
Set alert

Price alert · APRE

All alert types
0.45 USD 0.00 (+0.00%)

At closeNov 11, 2026, 8:46 AM EST

0.43 -0.02 -3.50%

Pre-market · Nov 11, 8:46 AM ET

Day range unavailable

0.41 52-week range 1.49
YTD
-47.76%
1 year
-64.91%

Revenue & Expenses

Other Income → Expenses: $1.36MExpenses → Gross Loss: $7.86MExpenses → Selling, General & Admin: $6.46MExpenses → Research & Development: $9.36MOther Operating Income → Expenses: $9.36MNet Loss → Expenses: $12.96MRevenue → Cost of Revenue: $1.50MOther Income$1.36MOther Operating Income$9.36MNet Loss$12.96MCost of Revenue$9.36MExpenses$23.68MGross Loss$7.86MSelling, General & Admin$6.46MResearch & Development$9.36MRevenue$1.50M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

APRE annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
285.76K1.50M583.23K00
285.76K1.50M583.23K00
285.76K1.50M583.23K00
13.52M15.82M16.06M113.39M37.45M
7.04M9.36M7.63M16.40M23.90M
6.48M6.46M8.43M20.97M13.55M
-13.23M-14.32M-15.47M-113.39M-37.45M
-652.09K-1.29M-1.22M-448.67K-1.65K
-12.60M-12.96M-14.29M-112.66M-37.13M
-12.60M-12.96M-14.29M-112.66M-37.13M
-12.60M-12.96M-14.29M-112.66M-37.13M
-12.60M-12.96M-14.29M-112.66M-37.13M
-1.93-2.35-3.95-67.99-34.88
-1.93-2.35-3.95-67.99-34.88
-1.93-2.35-3.95-67.99-34.88
-13.25M-14.25M-15.51M-113.11M-37.13M
-13.25M-14.25M-15.51M-113.11M-37.13M
6.54M5.51M3.62M1.66M1.06M
6.54M5.51M3.62M1.66M1.06M